Buy Signalling Pathways of M918t Ret Mutant in Multiple Endocrine Neoplasia Type 2b
close menu
Bookswagon
search
My Account
Book 1
Book 2
Book 3
Book 1
Book 2
Book 3
Book 1
Book 2
Book 3
Book 1
Book 2
Book 3
Signalling Pathways of M918t Ret Mutant in Multiple Endocrine Neoplasia Type 2b

Signalling Pathways of M918t Ret Mutant in Multiple Endocrine Neoplasia Type 2b


     0     
5
4
3
2
1



Out of Stock


Notify me when this book is in stock
X
About the Book

This dissertation, "Signalling Pathways of M918T RET Mutant in Multiple Endocrine Neoplasia Type 2B" by 陳展豪, Chin-ho, Chan, was obtained from The University of Hong Kong (Pokfulam, Hong Kong) and is being sold pursuant to Creative Commons: Attribution 3.0 Hong Kong License. The content of this dissertation has not been altered in any way. We have altered the formatting in order to facilitate the ease of printing and reading of the dissertation. All rights not granted by the above license are retained by the author. Abstract: Abstract of thesis entitled Signalling pathways of M918T RET mutant in Multiple Endocrine Neoplasia type 2B Submitted by Chan Chin Ho For the degree of Master of Philosophy at The University of Hong Kong in August 2005 Multiple endocrine neoplasia type 2B (MEN2B) is an inherited cancer syndrome characterized by the presence of medullary thyroid carcinoma and phaeochromocytoma. A single amino acid substitution (M918T) in the RET receptor tyrosine kinase was found in more than 95% of the patients. This mutation is believed to lead to constitutive activation and altered substrate specificity of the RET receptor, which resulted in cellular transformation. There are two predominant isoforms of RET, designated as RET51 and RET9, as a result of alternative splicing. To screen for the possible components of M918T mutant RET (RET/MEN2B) signaling pathways, the profiles of the phosphorylated proteins of RET51/MEN2B and RET9/MEN2B transfected cells were compared with that of either wild type RET or empty vector transfected cells. In brief, serine-, threonine- and tyrosine-phosphorylated proteins of the transfected NIH3T3 cells were isolated by affinity chromatography and resolved by SDS-PAGE. Then the protein bands differentially displayed in the lane of phosphorylated proteins from cells expressing iRET/MEN2B were identified by mass spectrometry. Four protein bands were identified to be upregulated in RET51/MEN2B cells: Tubulin beta-2 chain, UDP- glucose dehydrogenase (UGDH), alpha enolase, and placenta and embryonic expression gene; while peroxiredoxin 1 was upregulated in RET9/MEN2B cells. UGDH is a key enzyme responsible for extracellular matrix production and its activity is upregulated by phosphorylation. UGDH is important in Wg signaling in Drosophila, the homologue of mammalian Wnt. Therefore the regulation of β-catenin, the main component of Wnt signaling pathway, was studied in RET51/MEN2B expressing cells. The results suggested that the β-catenin signaling pathway was activated by RET51/MEN2B. First, immunocytochemistry showed that RET51/MEN2B may promote the translocation of plasma membrane bound β-catenin into the cytoplasm; Second, western analysis showed that RET51/MEN2B may stabilize cytosolic β-catenin by inhibiting the association between β-catenin and GSK3β, a protein which normally targets β-catenin to the degradation pathway. This outweighed the opposite destabilizing effect exerted by both RET/MEN2B and GDNF stimulated RET51/WT. In both cell types, GSK3β is dephosphorylated at Ser9 which would lead to association between β-catenin and GSK3β. Third, this was supported by the data that there was an elevation of nuclear β-catenin in RET51/MEN2B cells, which may result from stabilisation of cytosolic β-catenin followed by transfer of β-catenin into the nucleus. Finally, preliminary results suggested that blocking of UGDH activity by its specific inhibitor, piperine (100μM), negatively regulates the β-catenin signaling in RET51/MEN2B and empty vector transfected clones. Taken together, the findings suggested that UGDH might act as an upstream regulator of the RET51/MEN2B mediated β-catenin signaling pathway. ii DOI: 10.5353/th_b3460324 Subjects: Oncogenes Protein-tyrosine kinase Cellular signal transduction Endocrine glands - Cancer - Genetic aspects


Best Sellers


Product Details
  • ISBN-13: 9781361049624
  • Publisher: Open Dissertation Press
  • Publisher Imprint: Open Dissertation Press
  • Height: 279 mm
  • No of Pages: 144
  • Weight: 626 gr
  • ISBN-10: 1361049626
  • Publisher Date: 26 Jan 2017
  • Binding: Hardback
  • Language: English
  • Spine Width: 10 mm
  • Width: 216 mm


Similar Products

Add Photo
Add Photo

Customer Reviews

REVIEWS      0     
Click Here To Be The First to Review this Product
Signalling Pathways of M918t Ret Mutant in Multiple Endocrine Neoplasia Type 2b
Open Dissertation Press -
Signalling Pathways of M918t Ret Mutant in Multiple Endocrine Neoplasia Type 2b
Writing guidlines
We want to publish your review, so please:
  • keep your review on the product. Review's that defame author's character will be rejected.
  • Keep your review focused on the product.
  • Avoid writing about customer service. contact us instead if you have issue requiring immediate attention.
  • Refrain from mentioning competitors or the specific price you paid for the product.
  • Do not include any personally identifiable information, such as full names.

Signalling Pathways of M918t Ret Mutant in Multiple Endocrine Neoplasia Type 2b

Required fields are marked with *

Review Title*
Review
    Add Photo Add up to 6 photos
    Would you recommend this product to a friend?
    Tag this Book Read more
    Does your review contain spoilers?
    What type of reader best describes you?
    I agree to the terms & conditions
    You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.

    CUSTOMER RATINGS AND REVIEWS AND QUESTIONS AND ANSWERS TERMS OF USE

    These Terms of Use govern your conduct associated with the Customer Ratings and Reviews and/or Questions and Answers service offered by Bookswagon (the "CRR Service").


    By submitting any content to Bookswagon, you guarantee that:
    • You are the sole author and owner of the intellectual property rights in the content;
    • All "moral rights" that you may have in such content have been voluntarily waived by you;
    • All content that you post is accurate;
    • You are at least 13 years old;
    • Use of the content you supply does not violate these Terms of Use and will not cause injury to any person or entity.
    You further agree that you may not submit any content:
    • That is known by you to be false, inaccurate or misleading;
    • That infringes any third party's copyright, patent, trademark, trade secret or other proprietary rights or rights of publicity or privacy;
    • That violates any law, statute, ordinance or regulation (including, but not limited to, those governing, consumer protection, unfair competition, anti-discrimination or false advertising);
    • That is, or may reasonably be considered to be, defamatory, libelous, hateful, racially or religiously biased or offensive, unlawfully threatening or unlawfully harassing to any individual, partnership or corporation;
    • For which you were compensated or granted any consideration by any unapproved third party;
    • That includes any information that references other websites, addresses, email addresses, contact information or phone numbers;
    • That contains any computer viruses, worms or other potentially damaging computer programs or files.
    You agree to indemnify and hold Bookswagon (and its officers, directors, agents, subsidiaries, joint ventures, employees and third-party service providers, including but not limited to Bazaarvoice, Inc.), harmless from all claims, demands, and damages (actual and consequential) of every kind and nature, known and unknown including reasonable attorneys' fees, arising out of a breach of your representations and warranties set forth above, or your violation of any law or the rights of a third party.


    For any content that you submit, you grant Bookswagon a perpetual, irrevocable, royalty-free, transferable right and license to use, copy, modify, delete in its entirety, adapt, publish, translate, create derivative works from and/or sell, transfer, and/or distribute such content and/or incorporate such content into any form, medium or technology throughout the world without compensation to you. Additionally,  Bookswagon may transfer or share any personal information that you submit with its third-party service providers, including but not limited to Bazaarvoice, Inc. in accordance with  Privacy Policy


    All content that you submit may be used at Bookswagon's sole discretion. Bookswagon reserves the right to change, condense, withhold publication, remove or delete any content on Bookswagon's website that Bookswagon deems, in its sole discretion, to violate the content guidelines or any other provision of these Terms of Use.  Bookswagon does not guarantee that you will have any recourse through Bookswagon to edit or delete any content you have submitted. Ratings and written comments are generally posted within two to four business days. However, Bookswagon reserves the right to remove or to refuse to post any submission to the extent authorized by law. You acknowledge that you, not Bookswagon, are responsible for the contents of your submission. None of the content that you submit shall be subject to any obligation of confidence on the part of Bookswagon, its agents, subsidiaries, affiliates, partners or third party service providers (including but not limited to Bazaarvoice, Inc.)and their respective directors, officers and employees.

    Accept


    Inspired by your browsing history


    Your review has been submitted!

    You've already reviewed this product!